Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Statens Serum Institut
Statens Serum Institute
Statens Serum Institute_20100121
  

Statens Serum Institut patents

Recent patent applications related to Statens Serum Institut. Statens Serum Institut is listed as an Agent/Assignee. Note: Statens Serum Institut may have other listings under different names/spellings. We're not affiliated with Statens Serum Institut, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "S" | Statens Serum Institut-related inventors




Date Statens Serum Institut patents (updated weekly) - BOOKMARK this page
01/27/11Therapeutic tb vaccine
01/21/10Vaccines comprising tb 10.4
01/21/10Vaccines comprising tb 10.4
08/31/17Alpha-tocopherol-based adjuvanted solvent for dna vaccines
02/16/17New m.tuberculosis vaccines
01/19/17Diagnostic reagents for improved in vivo or in vitro cell-mediated immunological diagnosis of tuberculosis
10/15/15M. tuberculosis vaccines
10/15/15Method of diagnosing galactosemia in neonatal screening
04/02/15Tuberculosis tb vaccine to prevent reactivation
09/18/14Vaccines against chlamydia sp.
07/24/14Modified cationic liposome adjuvants
06/19/14Production of a cysteine rich protein
06/05/14Pcr diagnostics of dermatophytes and other pathogenic fungi
04/24/14Methods for producing liposomes
06/13/13Therapeutic tb vaccine
04/18/13Tuberculosis vaccines comprising antigens expressed during the latent infection phase
06/21/12Expanding the t cell repertoire to include subdominant epitopes by vaccination with antigens delivered as protein fragments or peptide cocktails
05/10/12Tuberculosis vaccines comprising antigens expressed during the latent infection phase
02/16/12Tuberculosis tb vaccine to prevent reactivation
01/19/12Vaccines comprising tb10.4
11/24/11Modified cationic liposome adjuvans
10/13/11Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
09/22/11Optimized influenza vaccines
08/25/11Tuberculosis vaccines comprising antigens expressed during the latent infection phase
01/27/11Malaria vaccine
12/09/10The use of monomycolyl glycerol (mmg) as an adjuvant
12/09/10Pcr diagnostics of dermatophytes and other pathogenic fungi
09/09/10Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
06/24/10Influenza vaccines
07/23/09Tuberculosis vaccines comprising antigens expressed during the latent infection phase
03/12/09Compositions and means for diagnosing microbial infections







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Statens Serum Institut in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Statens Serum Institut with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';